Skip to main content
. Author manuscript; available in PMC: 2024 Aug 15.
Published in final edited form as: Adv Funct Mater. 2023 May 1;33(33):2302777. doi: 10.1002/adfm.202302777

Figure 5.

Figure 5.

Cytotoxicity and in vitro CRIT efficacy of MEP5 and TPP NPs. Cell viability of 4T1 cancer cells was measured by adding (a) MEP5, (b) TPP NPs, or (c) 89Zr-DFO to the culture media at various concentrations or radioactivity levels. (d) CRIT efficacy of MEP5 and TPP NPs was compared at equivalent TPP concentrations when activated by 150 μCi of Zr-89.